Global study tracks Alzheimer's drugs in real patients

NCT ID NCT07420075

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: CorEvitas Source: ClinicalTrials.gov ↗

Summary

This study is creating a global registry to track how Alzheimer's treatments work in real-world settings. It will follow 2,000 patients with Alzheimer's or related conditions during their regular doctor visits. The goal is to understand the long-term safety and effectiveness of standard Alzheimer's medications as they're actually used in practice.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CorEvitas, LLC

    Waltham, Massachusetts, 02451, United States

Conditions

Explore the condition pages connected to this study.